Document is current
Any future updates will be listed below
-
Authors
Nabers, Andreas
Perna, Laura
Lange, Julia
Mons, Ute
Schartner, Jonas
Güldenhaupt, Jörn
Saum, Kai‐Uwe
Janelidze, Shorena
Holleczek, Bernd
Rujescu, Dan
Hansson, Oskar https://orcid.org/0000-0001-8467-7286
Gerwert, Klaus https://orcid.org/0000-0001-8759-5964
Brenner, Hermann
-
Funding
Funding for this research was provided by:
Baden‐Württemberg Ministry of Science, Research and Arts
German Federal Ministry of Education and Research
German Federal Ministry of Family, Senior Citizens, Women and Youth
Saarland Ministry of Social Affairs, Health, Women and Family
Network Aging Research at the University of Heidelberg
Protein Research Unit Ruhr within Europe
Ministry of Innovation, Science and Research of North‐Rhine Westphalia, Germany
European Research Council, Swedish Research Council
Swedish Alzheimer Association
Ministerium für Wissenschaft, Forschung und Kunst Baden‐Württemberg
Hjärnfonden
Roche
GE|GE Healthcare
Biogen
Fujirebio Europe
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 7 December 2017
Revised: 2 March 2018
Accepted: 6 March 2018
First Online: 6 April 2018
Conflict of interest
: Dr. Hansson has received research support (for the institution) from Roche, GE Healthcare, Biogen, AVID Radiopharmaceuticals, Fujirebio and Euroimmun. In the past 2 years, he has received consultancy/speaker fees (paid to the institution) from Lilly, Roche and Fujirebio.
